As an mTOR inhibitor, rapamycin is expected to improve autophagy flux47 in ME/CFS patients, and increasing levels of serum BECLIN-1 are considered reliable markers for the overall improvement of autophagy flux48,49. The gene discussed is MTOR; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.